Kim Kamdar

Kim Kamdar

Chairman at SERA PROGNOSTICS, INC.

Net worth: 68 034 $ as of 2024-03-30

56 year
Health Technology
Finance
Health Services

Profile

Kim Puloma Kamdar founded Truvian Sciences, Inc. in 2015, where she is working as Chairman.
Dr. Kamdar also founded Aryzun Pharmaceuticals and Seraphina Therapeutics, Inc., where she is working as Chairman.
Dr. Kamdar also currently works at Sera Prognostics, Inc., as Chairman from 2023, ROX Medical, Inc., as Director, One Palmer Square Associates VII LLC, as Director, San Diego Venture Group, as Director, The Hastings Center, as Director, Epic Sciences, Inc., as Director, Connect Foundation, as Director, SalveoDx, as Director, Evofem Biosciences, Inc., as Independent Director, Singular Genomics Systems, Inc., as Independent Director from 2017, Alume Biosciences, Inc., as Director from 2020, Epitel, Inc., as Director & Partner, Access Youth Academy, as Director, Pleno, Inc., as Director, Domain Associates LLC, as Partner from 2011, One Palmer Square Associates VIII LLC, as Managing Member, Domain LLC, as Partner from 2011, Adjuvant Capital LP, as Advisory Partner, and Medical Excellence Capital LLC, as Managing Partner from 2021.
Dr. Kamdar also formerly worked at Aspen Neuroscience, Inc., as Chairman & Chief Executive Officer, Obalon Therapeutics, Inc., as Chairman from 2020 to 2021, Corthera, Inc., as Director, Novartis International AG, as Research Director, Achaogen, Inc., as Director, BiPar Sciences, Inc., as Director, Adastra Pharmaceuticals, Inc., as Director, Syndax Pharmaceuticals, Inc., as Independent Director from 2006 to 2017, Omniome LLC, as Director, Sonexa Therapeutics, Inc., as Director, Nuon Therapeutics, Inc., as Director, Altair Therapeutics, Inc., as Director, Neothetics, Inc., as Director from 2011 to 2014, Ariosa Diagnostics, Inc., as Director from 2010 to 2015, MPM BioImpact, Inc, as Principal in 2004, Torrey Mesa Research Institute, as Program Leader, and Bill & Melinda Gates Foundation, as Advisor.
Dr. Kamdar received her doctorate degree in 1995 from Emory University and undergraduate degree in 1988 from Northwestern University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-07 6,629 ( 0.02% ) 60 324 $ 2024-03-30
2023-05-24 15,000 ( 0.02% ) 7 710 $ 2024-03-30
2024-03-14 0 ( -.--% ) - $ 2024-03-30

Kim Kamdar active positions

CompaniesPositionStart
SERA PROGNOSTICS, INC. Chairman 2023-06-07
SINGULAR GENOMICS SYSTEMS, INC. Director/Board Member 2017-04-30
EVOFEM BIOSCIENCES, INC. Director/Board Member 2017-12-31
Private Equity Investor 2004-12-31
Connect Foundation Director/Board Member -
SalveoDx Director/Board Member -
Founder 2014-12-31
One Palmer Square Associates VII LLC Director/Board Member -
Consultant / Advisor -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Kim Kamdar

Former positions of Kim Kamdar

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Kim Kamdar's experience

Training of Kim Kamdar

Emory University Doctorate Degree
Northwestern University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kim Kamdar's experience

Connections

100 +

1st degree connections

41

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
SYNDAX PHARMACEUTICALS, INC.

Health Technology

SERA PROGNOSTICS, INC.

Health Services

EVOFEM BIOSCIENCES, INC.

Health Technology

SINGULAR GENOMICS SYSTEMS, INC.

Health Technology

Private companies35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

One Palmer Square Associates VII LLC

Health Technology

Health Technology

Finance

Distribution Services

Health Technology

One Palmer Square Associates VIII LLC

Aryzun Pharmaceuticals

Health Services

The Hastings Center

Health Technology

Finance

Connect Foundation

SalveoDx

Health Services

Health Services

Commercial Services

Finance

Technology Services

Commercial Services

Consumer Services

Health Services

Technology Services

Finance

See company connections